Evidence map›Paper›PMID 31781312›Full record

ArticleDisease markers2019

Preoperative Plasma Fibrinogen and Serum Albumin Score Is an Independent Prognostic Factor for Resectable Stage II-III Gastric Cancer.

Menghui Wu, Yuchen Pan, Zhifang Jia, Yueqi Wang, Na Yang, Jianfeng Mu, Tianyu Zhou, Yaohua Guo, Jing Jiang, Xueyuan Cao

Abstract read
In one paragraph

Article in Disease markers, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Nomogram for predicting overall survival after curative gastrectomy using inflammatory, nutritional and pathological factors.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. High fibrinogen-albumin ratio index (FARI) predicts poor survival in head and neck squamous cell carcinoma patients treated with surgical resection.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Menghui WuDepartment of Gastric and Colorectal Surgery, The First Hospital of Jilin University, Changchun, China.ORCID https://orcid.org/0000-0003-4659-5639
Yuchen PanDivision of Clinical Research, The First Hospital of Jilin University, Changchun, China.
Zhifang JiaDivision of Clinical Research, The First Hospital of Jilin University, Changchun, China.
Yueqi WangDivision of Clinical Research, The First Hospital of Jilin University, Changchun, China.
Na YangDivision of Clinical Research, The First Hospital of Jilin University, Changchun, China.
Jianfeng MuDepartment of Gastric and Colorectal Surgery, The First Hospital of Jilin University, Changchun, China.
Tianyu ZhouDepartment of Gastric and Colorectal Surgery, The First Hospital of Jilin University, Changchun, China.
Yaohua GuoDepartment of Gastric and Colorectal Surgery, The First Hospital of Jilin University, Changchun, China.
Jing JiangDivision of Clinical Research, The First Hospital of Jilin University, Changchun, China.ORCID https://orcid.org/0000-0001-9714-9255
Xueyuan CaoDepartment of Gastric and Colorectal Surgery, The First Hospital of Jilin University, Changchun, China.ORCID https://orcid.org/0000-0002-1982-1672

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRadical gastrectomy with D2 lymphadenectomy is recognized as the standard treatment for resectable advanced gastric cancer. Preoperative fibrinogen and albumin measurements may bring clinical benefits in terms of providing advanced notice of a poor prognosis or recurrence in patients undergoing radical resection. The aim of this study was to identify markers that are predictive of a poor prognosis prior to surgery.

methodsEight hundred forty-two consecutive patients who underwent curative radical gastrectomy at our hospital between 2008 and 2012 were retrospectively reviewed. Based on plasma fibrinogen and serum albumin levels, preoperative fibrinogen and albumin scores (Fib-Alb scores) were investigated, and the prognostic significance was determined.

resultsThe patients were classified according to a Fib-Alb score of 0 (

conclusionsThe prognosis of patients with high fibrinogen and low albumin levels is poor. The Fib-Alb score was shown to be an independent prognostic factor for postoperative recurrence in gastric cancer patients who underwent radical gastrectomy.

Indexed as

AdenocarcinomaBiomarkers, TumorCarcinoma, Signet Ring CellC-Reactive ProteinFemaleFibrinogenFollow-Up StudiesGastrectomyHumansLymph Node ExcisionMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPreoperative CareRetrospective StudiesBiomarkers, TumorC-Reactive ProteinFibrinogenSerum Albumin

Identifiers

PMID31781312
PMCPMC6875287

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.